Clinical score and rapid antigen detection test to guide antibiotic use for sore throats: randomised controlled trial of PRISM (primary care streptococcal management)

Abstract

Objective To determine the effect of clinical scores that predict streptococcal infection or rapid streptococcal antigen detection tests compared with delayed antibiotic prescribing.Design Open adaptive pragmatic parallel group randomised controlled trial.Setting Primary care in United Kingdom.Patients Patients aged ≥3 with acute sore throat.Intervention An internet programme randomised patients to targeted antibiotic use according to: delayed antibiotics (the comparator group for analyses), clinical score, or antigen test used according to clinical score. During the trial a preliminary streptococcal score (score 1, n=1129) was replaced by a more consistent score (score 2, n=631; features: fever during previous 24 hours; purulence; attends rapidly (within three days after onset of symptoms); inflamed tonsils; no cough/coryza (acronym FeverPAIN).Outcomes Symptom severity reported by patients on a 7 point Likert scale (mean severity of sore throat/difficulty swallowing for days two to four after the consultation (primary outcome)), duration of symptoms, use of antibiotics.Results For score 1 there were no significant differences between groups. For score 2, symptom severity was documented in 80% (168/207 (81%) in delayed antibiotics group; 168/211 (80%) in clinical score group; 166/213 (78%) in antigen test group). Reported severity of symptoms was lower in the clinical score group (−0.33, 95% confidence interval −0.64 to −0.02; P=0.04), equivalent to one in three rating sore throat a slight versus moderate problem, with a similar reduction for the antigen test group (−0.30, −0.61 to −0.00; P=0.05). Symptoms rated moderately bad or worse resolved significantly faster in the clinical score group (hazard ratio 1.30, 95% confidence interval 1.03 to 1.63) but not the antigen test group (1.11, 0.88 to 1.40). In the delayed antibiotics group, 75/164 (46%) used antibiotics. Use of antibiotics in the clinical score group (60/161) was 29% lower (adjusted risk ratio 0.71, 95% confidence interval 0.50 to 0.95; P=0.02) and in the antigen test group (58/164) was 27% lower (0.73, 0.52 to 0.98; P=0.03). There were no significant differences in complications or reconsultations.Conclusion Targeted use of antibiotics for acute sore throat with a clinical score improves reported symptoms and reduces antibiotic use. Antigen tests used according to a clinical score provide similar benefits but with no clear advantages over a clinical score alone.Trial registration ISRCTN32027234

Antibiotic overuse: a key driver of antimicrobial resistance

“…4 Further there is little evidence that antibiotic treatment has a significant impact on the duration or severity of symptoms. 5 Across the UK there is marked variation in antibiotic prescribing with some practices prescribing at double the rate of lowprescribing practices (Figure 1 …”

Influence of the duration of penicillin prescriptions on outcomes for acute sore throat in adults: the DESCARTE prospective cohort study in UK general practice

“…The diary was similar to that used in other studies. 28,31 Patients completed the diary each night until symptoms resolved or up to 14 nights. Each symptom sore throat, difficulty swallowing, feeling unwell, fevers, sleep disturbance was scored (0=no problem to 6=as bad as it could be): Symptomatic outcomes were only available for those returning diaries.…”

Controlling acute rheumatic fever and rheumatic heart disease in developing countries

“…However, the emergence of rapid antigen detection tests (RADTs) and the proliferation of clinical decision rules allow for new diagnostic approaches. RADTs can be reliable, however, their performance varies; specificity ranges from 8.3 to 98.2% [55] and sensitivity 42-95% [56,57]. In one study, inadequate staff training substantially reduced the accuracy of the tests [55].…”